New hope for night-time cluster headache sufferers: sleep drug xywav tested in trial
NCT ID NCT06950281
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tests whether a low-sodium form of oxybate (Xywav) can reduce the number of nighttime cluster headache attacks in people with chronic cluster headache. About 52 adults will take either the drug or a placebo twice nightly for 16 weeks. The main goal is to see if the drug lowers the weekly count of headaches that wake people from sleep.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CLUSTER HEADACHE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.